SCHEMBL1626634

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL1626674	0.90	SPR (0.41)	SPREGLN1VEGFAFLT1EGLN3
	SCHEMBL1626932	0.88	SPR (0.47)	SPREGLN1VEGFAFLT1EGLN3
	SCHEMBL12720376	0.88	SPR (0.44)	SPREGLN1VEGFAFLT1MEN1
	SCHEMBL1626661	0.82	SPR (0.52)	SPREGLN1VEGFAFLT1EGLN3
	SCHEMBL1627956	0.82	SPR (0.50)	SPREGLN1VEGFAFLT1EGLN3
	SCHEMBL1625804	0.82	SPR (0.43)	SPRKMT2AALDH1A1KDM4EGAA
	SCHEMBL1627289	0.81	PTPRC (0.43)	SPREGLN1VEGFAFLT1EGLN3
	SCHEMBL12720427	0.80	SPR (0.42)	SPREGLN1EGLN3
	SCHEMBL1625411	0.80	EGLN1 (0.45)	SPREGLN1VEGFAFLT1EGLN3
	SCHEMBL12720437	0.79	CYP11B2 (0.38)	SPREGLN1VEGFAFLT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.